These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8544456)
21. [Medullary cancer of the thyroid. Experience at the Hospital de Valdivia]. Pérez JA; Salinas P; Poblete MT; Silva R; Cardemil B; Krauskopf V; Soto C Rev Med Chil; 1996 Jun; 124(6):707-14. PubMed ID: 9041728 [TBL] [Abstract][Full Text] [Related]
22. [Decision making in postoperative incidentally found small C-cell-carcinoma]. Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440 [TBL] [Abstract][Full Text] [Related]
24. Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis. Meijer JA; le Cessie S; van den Hout WB; Kievit J; Schoones JW; Romijn JA; Smit JW Clin Endocrinol (Oxf); 2010 Apr; 72(4):534-42. PubMed ID: 19563448 [TBL] [Abstract][Full Text] [Related]
25. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469 [TBL] [Abstract][Full Text] [Related]
26. Radioactive iodine treatment in medullary thyroid carcinoma. Faik Erdogan M; Gursoy A; Erdogan G; Kamel N Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922 [TBL] [Abstract][Full Text] [Related]
27. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis. Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558 [TBL] [Abstract][Full Text] [Related]
28. Should patients with medullary thyroid carcinoma undergo extensive lymph node (re)operation to improve long-term survival? Brumsen C; Haak HR; Goslings BM; van de Velde CJ Henry Ford Hosp Med J; 1992; 40(3-4):271-5. PubMed ID: 1483874 [TBL] [Abstract][Full Text] [Related]
29. [The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma]. Raue F; Geiger S; Buhr H; Frank-Raue K; Ziegler R Dtsch Med Wochenschr; 1993 Jan; 118(3):49-52. PubMed ID: 8425457 [TBL] [Abstract][Full Text] [Related]
30. [Multiple endocrine type 2 neoplasia in 3 families]. Palchik M; Sánchez A; Góméz J; Rodríguez Pécora A Medicina (B Aires); 1990; 50(2):117-23. PubMed ID: 1983220 [TBL] [Abstract][Full Text] [Related]
31. Medullary carcinoma of the thyroid gland. Gogas J; Markopoulos C; Skandalakis P; Sechas M Am Surg; 1987 Jun; 53(6):347-9. PubMed ID: 3579051 [TBL] [Abstract][Full Text] [Related]
32. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. Girelli ME; Nacamulli D; Pelizzo MR; De Vido D; Mian C; Piccolo M; Busnardo B Thyroid; 1998 Jun; 8(6):517-23. PubMed ID: 9669290 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma. Hay ID; Ryan JJ; Grant CS; Bergstralh EJ; van Heerden JA; Goellner JR Surgery; 1990 Dec; 108(6):972-9; discussion 979-80. PubMed ID: 2247843 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome. Samaan NA; Yang KP; Schultz P; Hickey RC Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946 [TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF; J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497 [TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course. Leboulleux S; Travagli JP; Caillou B; Laplanche A; Bidart JM; Schlumberger M; Baudin E Cancer; 2002 Jan; 94(1):44-50. PubMed ID: 11815959 [TBL] [Abstract][Full Text] [Related]
37. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience. Samulski TD; Livolsi VA; Montone K; Baloch Z Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099 [TBL] [Abstract][Full Text] [Related]
38. [Value of the assay of plasma carcinoembryonic antigen and thyrocalcitonin in the detection of medullary cancer of the thyroid with amyloid stroma. Results of a familial survey of 47 subjects]. Allanic H Ann Med Interne (Paris); 1984; 135(5):341-4. PubMed ID: 6486613 [TBL] [Abstract][Full Text] [Related]
39. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times. Papapetrou PD; Polymeris A Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112 [TBL] [Abstract][Full Text] [Related]
40. [Medullary carcinoma of the thyroid gland. Personal experience]. Neradilová M; Nĕmec J; Vlcek P; Soutorová M; Bednár J Cesk Pediatr; 1992 Aug; 47(8):449-52. PubMed ID: 1394547 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]